UK markets open in 5 minutes
NIKKEI 225
38,617.10 -329.83 (-0.85%) HANG SENG
19,210.59 -10.03 (-0.05%) CRUDE OIL
79.06 -0.20 (-0.25%) GOLD FUTURES
2,419.30 -6.60 (-0.27%) DOW
39,872.99 +66.22 (+0.17%) Bitcoin GBP
54,737.93 -1,076.98 (-1.93%)
Excelsior Biopharma Inc. (6496.TWO)
Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
At close: 12:37PM CST
Currency in TWD
Valuation measures4
| Market cap (intra-day) | 1.33B |
| Enterprise value | 1.29B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.72 |
| Price/book (mrq) | 1.25 |
| Enterprise value/revenue | 1.67 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -14.00% |
| S&P500 52-week change 3 | 29.31% |
| 52-week high 3 | 33.25 |
| 52-week low 3 | 27.00 |
| 50-day moving average 3 | 28.13 |
| 200-day moving average 3 | 28.48 |
Share statistics
| Avg vol (3-month) 3 | 16.15k |
| Avg vol (10-day) 3 | 12k |
| Shares outstanding 5 | 46.99M |
| Implied shares outstanding 6 | 46.99M |
| Float 8 | N/A |
| % held by insiders 1 | 59.53% |
| % held by institutions 1 | 1.79% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | 6.35 |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 13 Jul 2021 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -13.03% |
| Operating margin (ttm) | -15.23% |
Management effectiveness
| Return on assets (ttm) | -3.31% |
| Return on equity (ttm) | -8.98% |
Income statement
| Revenue (ttm) | 773.69M |
| Revenue per share (ttm) | 16.84 |
| Quarterly revenue growth (yoy) | 1.10% |
| Gross profit (ttm) | N/A |
| EBITDA | -66.71M |
| Net income avi to common (ttm) | -100.78M |
| Diluted EPS (ttm) | -2.19 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 497.73M |
| Total cash per share (mrq) | 10.79 |
| Total debt (mrq) | 451.19M |
| Total debt/equity (mrq) | 42.43% |
| Current ratio (mrq) | 4.14 |
| Book value per share (mrq) | 23.05 |
Cash flow statement
| Operating cash flow (ttm) | -102.84M |
| Levered free cash flow (ttm) | -284.48M |
© 2024 Yahoo. All rights reserved.